Concepedia

Elza Lomaia

EL

5

Publications

574

Citations

5

H-Index

2017

Active since

Affiliations

Federal Almazov North-West Medical Research Centre(Current)

Jena University Hospital

Russian Research Institute of Hematology and Transfusiology

Princess Margaret Cancer Centre

First Pavlov State Medical University of St. Petersburg

Elza Lomaia is an author at Federal Almazov North-West Medical Research Centre specializing in hematology, diagnosis, and cancer research.

ORCID

Top concepts

Publications per year

2017–2024

5

Publications

5

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Delphine Réa, Michael J. Mauro, Carla Boquimpani et al. · Blood · 2021 · 319 citations · Full text

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Jörge E. Cortes, Jane F. Apperley, Elza Lomaia et al. · Blood · 2021 · 185 citations · Full text

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

A. L. Melikyan, Irina N. Subortseva, Vasily Shuvaev et al. · Clinical oncohematology · 2021 · 25 citations · Full text

, , +13

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry

Annamaria Brioli, Elza Lomaia, Christian Fabisch et al. · Leukemia · 2024 · 23 citations · Full text

Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia

Anna Turkina, A.Yu. Zaritskii, Vasily Shuvaev et al. · Clinical oncohematology · 2017 · 22 citations · Full text

Rows per page

1–5 of 5